
News|Articles|December 1, 2023
AAO 2023: Luminopia, first FDA-approved digital therapeutic for amblyopia
Author(s)David Hutton, Sheryl Stevenson
Rupa Wong, MD, spoke with the Ophthalmology Times team about Luminopia, the first FDA-approved digital therapeutic for amblyopia at this year's American Academy of Ophthalmology meeting.
Advertisement
Rupa Wong, MD, spoke with the Ophthalmology Times team about Luminopia, the first FDA-approved digital therapeutic for amblyopia at this year's American Academy of Ophthalmology meeting.
Advertisement
Latest CME
Advertisement
Advertisement
















